BioSpace News Archive

Validive ® Phase 2b/3 Clinical Trial on Track to Start Before Year-end Issuance of New Patents For Validive Camsirubicin Phase 2 Clinical Trial to Start Late 2020/Early 2021 WILMETTE, Ill., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Monopar or the Company) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company primarily focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients, today annou

InMed Pharmaceuticals Inc. Announces Pricing of US$8M Public Offering and Listing on the Nasdaq Capital Market Under the Symbol “INM”

Discovery Life Sciences™, a global leader in biospecimen solutions, genomic, cell, and immunohistochemistry services, announces the addition of Illumina’s TruSight Oncology 500 technology to HudsonAlpha Discovery, Discovery’s highly recognized and regarded sequencing and bioinformatics laboratory.

Lexogen GmbH, a Vienna-based market leader in Next-Generation Sequencing (NGS) and transcriptomics announced today the launch of a pioneering ultra-high-throughput SARS-CoV-2 test that will allow for the first time a true mass screening of the whole population.

This program, dedicated to the education of fellows and residents, offers a unique opportunity to share notable retina research with peers and mentors

Selva Therapeutics, Inc. announced today that the company has received U.S. Food and Drug Administration (FDA) clearance of an Investigational New Drug (IND) application for SLV213 for the treatment of COVID-19 and has dosed the first subjects in a Phase 1 clinical study. Selva also announced preclinical data demonstrating in several host cell

AngioDynamics, Inc., a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, announced the safety and efficacy results from the Registry of AngioVac* System Procedures In Detail database.

Astrotech Corporation reported its financial results for the first quarter of fiscal year 2021, which ended September 30, 2020.

The American Academy of Pediatrics has selected ArborMetrix as its partner to develop and grow a clinical registry to advance the health, well-being, and development of all children.

P360, a leading developer of technology for life sciences companies, today announced the BirdzAI ZING Communication Module.